Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats

Canadian Journal of Physiology and Pharmacology

Volumn 89, Issue 5, 2011, Pages 345-354

  Wang, Yun ^a   Zhang, Xin Hua ^a   Wang, Huai Liang ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Bmpr2; Cgki cyrillic; Endothelial apoptosis; Fluoxetine; Monocrotaline; Pulmonary arterial hypertension; Remodeling; Serotonin transporter; Ukrainian

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CASPASE 3; CYCLIC GMP; FLUOXETINE; MONOCROTALINE; SMAD1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; HEART RIGHT VENTRICLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT;

ANIMALS; APOPTOSIS; BETA CATENIN; BLOOD PRESSURE; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; CASPASE 3; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENDOTHELIAL CELLS; FLUOXETINE; GENE EXPRESSION; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; LUNG; MALE; MICROVESSELS; MONOCROTALINE; PHOSPHORYLATION; PULMONARY ARTERY; RATS; RATS, WISTAR; SMAD1 PROTEIN;

EID: 79958846644     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/y11-024     Document Type: Article

References (44)

1. Anitha, M., Shahnavaz, N., Qayed, E., Joseph, I., Gossrau, G., Mwangi, S., et al. 2010. BMP2 promotes differentiation of nitrergic and catecholaminergic enteric neurons through a Smad1- dependent pathway. Am. J. Physiol. Gastrointest. Liver Physiol. 298(3): G375-G383. doi:10.1152/ajpgi.00343.2009. PMID: 20007850.
2. Beppu, H., Lei, H., Bloch, K.D., and Li, E. 2005. Generation of a floxed allele of the mouse BMP type II receptor gene. Genesis, 41(3): 133-137. doi:10.1002/gene.20099. PMID:15736264.
3. Cohen, E.D., Ihida-Stansbury, K., Lu, M.M., Panettieri, R.A., Jones, P.L., and Morrisey, E.E. 2009. Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/ PDGFR pathway. J. Clin. Invest. 119(9): 2538-2549. doi:10.1172/JCI38079. PMID:19690384.
4. Crona, D., Harral, J., Adnot, S., Eddahibi, S., and West, J. 2009. Gene expression in lungs of mice lacking the 5-hydroxytryptamine transporter gene. BMC Pulm. Med. 9(1): 19-25. doi:10.1186/ 1471-2466-9-19. PMID:19426553.
5. Davies, R.J., and Morrell, N.W. 2008. Molecular mechanisms of pulmonary arterial hypertension: role of mutations in the bone morphogenetic protein type II receptor. Chest, 134(6): 1271-1277. doi:10.1378/chest.08-1341. PMID:19059957.
6. de Jesus Perez, V.A., Alastalo, T., Wu, J.C., Axelrod, J.D., Cooke, J. P., Amieva, M., and Rabinovitch, M. 2009. Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt - b-catenin and Wnt - RhoA - Rac1 pathways. J. Cell Biol. 184(1): 83-99. doi:10. 1083/jcb.200806049. PMID:19139264.
7. Eddahibi, S., Humbert, M., Fadel, E., Raffestin, B., Darmon, M., Capron, F., et al. 2001. Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension. J. Clin. Invest. 108(8): 1141- 1150. PMID:11602621.
8. Eddahibi, S., Morrell, N., d'Ortho, M.P., Naeije, R., and Adnot, S. 2002. Pathobiology of pulmonary arterial hypertension. Eur. Respir. J. 20(6): 1559-1572. doi:10.1183/09031936.02.00081302. PMID:12503718.
9. El-Bizri, N., Wang, L., Merklinger, S.L., Guignabert, C., Desai, T., Urashima, T., et al. 2008. Smooth muscle protein 22a-mediated patchy deletion of Bmpr1a impairs cardiac contractility but protects against pulmonary vascular remodeling. Circ. Res. 102 (3): 380-388. doi:10.1161/CIRCRESAHA.107.161059. PMID: 18079409.
10. Elliott, C.G. 2005. Genetics of pulmonary arterial hypertension: current and future implications. Semin. Respir. Crit. Care Med. 26(4): 365-371.doi:10.1055/s-2005-916150. PMID:16121312.
11. Farkas, L., Farkas, D., Ask, K., Möller, A., Gauldie, J., Margetts, P., et al. 2009. VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. J. Clin. Invest. 119(5): 1298-1311. doi:10.1172/JCI36136. PMID:19381013.
12. Foletta, V.C., Lim, M.A., Soosairajah, J., Kelly, A.P., Stanley, E.G., Shannon, M., et al. 2003. Direct signaling by the BMP type II receptor via the cytoskeletal regulator LIMK1. J. Cell Biol. 162(6): 1089-1098. doi:10.1083/jcb.200212060. PMID:12963706.
13. Guignabert, C., Izikki, M., Tu, L.I., Li, Z., Zadigue, P., Barlier-Mur, A.M., et al. 2006. Transgenic mice overexpressing the 5- hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension. Circ. Res. 98(10): 1323-1330. doi:10.1161/01.RES.0000222546.45372.a0. PMID:16614302.
14. Jurasz, P., Courtman, D., Babaie, S., and Stewart, D.J. 2010. Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials. Pharmacol. Ther. 126(1): 1-8. doi:10.1016/j. pharmthera.2009.12.006. PMID:20117135.
15. Kleppisch, T., and Feil, R. 2009. cGMP signaling in the mammalian brain:role in synaptic plasticity and behaviour. Handb. Exp. Pharmacol.191(191):549-579. doi:10.1007/978-3-540-68964- 5_24. PMID:19089345.
16. Li, X.Q., Hong, Y., Wang, Y., Zhang, X.H., and Wang, H.L. 2006. Sertraline protects against monocrotaline-induced pulmonary hypertension in rats. Clin. Exp. Pharmacol. Physiol. 33(11): 1047-1051. doi:10.1111/j.1440-1681.2006.04485.x. PMID: 17042913.
17. Liu, B.A., Li, Z.M., Su, Z.S., and She, X.L. 2010. Pathological differential diagnosis of solid-pseudopapillary neoplasm and endocrine tumors of the pancreas. World J. Gastroenterol. 16(8): 1025-1030. doi:10.3748/wjg.v16.i8.1025. PMID:20180245.
18. Lu, D., and Carson, D.A. 2009. Spiperone enhances intracellular calcium level and inhibits the Wnt signaling pathway. BMC Pharmacol. 9(1): 13-20. doi:10.1186/1471-2210-9-13. PMID: 19948059.
19. MacLean, M.R. 2007. Pulmonary hypertension and the serotonin hypothesis: where are we now? Int. J. Clin. Pract. 61(Suppl. 156): 27-31. doi:10.1111/j.1742-1241.2007.01497.x. PMID:17663674.
20. Maclean, M.R., and Dempsie, Y. 2010. The serotonin hypothesis of pulmonary hypertension revisited. Adv. Exp. Med. Biol. 661: 309- 322. doi:10.1007/978-1-60761-500-2_20. PMID:20204739.
21. Miller, K.J., and Hoffman, B.J. 1994. Adenosine 3 receptors regulate serotonin transport via nitric oxide and cGMP. J. Biol. Chem. 269(44): 27351-27356. PMID:7525554.
22. Mohamed, S.A., Misfeld, M., Hanke, T., Charitos, E.I., Bullerdiek, J., Belge, G., et al. 2010. Inhibition of caspase-3 differentially affects vascular smooth muscle cell apoptosis in the concave versus convex aortic sites in ascending aneurysms with a bicuspid aortic valve. Ann. Anat. 192(3): 145-150. doi:10.1016/j.aanat.2010.02. 006. PMID:20427168.
23. Morrell, N.W., Adnot, S., Archer, S.L., Dupuis, J., Jones, P.L., MacLean, M.R., et al. 2009. Cellular and molecular basis of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 54(1 Suppl): S20-S31. doi:10.1016/j.jacc.2009.04.018. PMID:19555855.
24. Morty, R.E., Nejman, B., Kwapiszewska, G., Hecker, M., Zakrzewicz, A., Kouri, F.M., et al. 2007. Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension. Arterioscler. Thromb. Vasc. Biol. 27(5): 1072-1078. doi:10.1161/ATVBAHA.107.141200. PMID:17347486.
25. Münzel, T., Feil, R., Mülsch, A., Lohmann, S.M., Hofmann, F., and Walter, U. 2003. Physiology and pathophysiology of vascular signaling controlled by guanosine 3′,5′-cyclic monophosphatedependent protein kinase. Circulation, 108(18): 2172-2183. doi:10.1161/01.CIR.0000094403.78467.C3. PMID:14597579.
26. Newman, J.H., Phillips, J.A., III, and Loyd, J.E. 2008. Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies. Ann. Intern. Med. 148(4): 278-283. PMID:18283205.
27. Otsuka, F. 2008. Pulmonary arterial hypertension and BMP system abnormality. Nippon Rinsho, 66(11): 2083-2090. PMID:19051724.
28. Rabinovitch, M. 2001. Linking a serotonin transporter polymorphism to vascular smooth muscle proliferation in patients with primary pulmonary hypertension. J. Clin. Invest. 108(8): 1109-1111. PMID:11602617.
29. Rabinovitch, M. 2005. Cellular and molecular pathobiology of pulmonary hypertension conference summary. Chest, 128(6 Suppl.): 642-646. doi:10.1378/chest.128.6_suppl.642S. PMID:16373886.
30. Ramos, M., Lamé, M.W., Segall, H.J., and Wilson, D.W. 2007. Monocrotaline pyrrole induces Smad nuclear accumulation and altered signaling expression in human pulmonary arterial endothelial cells. Vascul. Pharmacol. 46(6): 439-448. doi:10.1016/j. vph.2007.01.005. PMID:17336165.
31. Sage, E., Mercier, O., Van den Eyden, F., de Perrot, M., Barlier-Mur, A.M., Dartevelle, P., et al. 2008. Endothelial cell apoptosis in chronically obstructed and reperfused pulmonary artery. Respir. Res. 9(1): 19-28. doi:10.1186/1465-9921-9-19. PMID:18269754.
32. Schwappacher, R., Weiske, J., Heining, E., Ezerski, V., Marom, B., Henis, Y.I., et al. 2009. Novel crosstalk to BMP signaling: cGMPdependent kinase I modulates BMP receptor and Smad activity. EMBO J. 28(11): 1537-1550. doi:10.1038/emboj.2009.103. PMID:19424179.
33. Southwood, M., Jeffery, T.K., Yang, X., Upton, P.D., Hall, S.M., Atkinson, C., et al. 2008. Regulation of bone morphogenetic protein signaling in human pulmonary vascular development. J. Pathol. 214(1): 85-95. doi:10.1002/path.2261. PMID:17992660.
34. Steiner, J.A., Carneiro, A.M., Wright, J., Matthies, H.J., Prasad, H.C., Nicki, C.K., et al. 2009. cGMP-dependent protein kinase Ia associates with the antidepressant-sensitive serotonin transporter and dictates rapid modulation of serotonin uptake. Mol. Brain, 2(1): 26-37. doi:10.1186/1756-6606-2-26. PMID:19656393.
35. Sun, C.K., Yuen, C.M., Kao, Y.H., Chang, L.T., Chua, S., Sheu, J.J., et al. 2009. Propylthiouracil attenuates monocrotaline-induced pulmonary arterial hypertension in rats. Circ. J. 73(9): 1722-1730. doi:10.1253/circj.CJ-09-0074. PMID:19602776.
36. Takahashi, H., Goto, N., Kojima, Y., Tsuda, Y., Morio, Y., Muramatsu, M., and Fukuchi, Y. 2006. Downregulation of type II bone morphogenetic protein receptor in hypoxic pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 290(3): 450-458 doi:10.1152/ajplung.00206.2005. PMID:16361357.
37. Tuder, R.M., Yeager, M.E., Geraci, M., Golpon, H.A., and Voelkel, N.F. 2001. Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene. Eur. Respir. J. 17(6): 1065-1069. doi:10.1183/09031936.01.00202701. PMID:11491145.
38. Upton, P.D., and Morrell, N.W. 2009. TGF-b and BMPR-II pharmacology implications for pulmonary vascular diseases. Curr. Opin. Pharmacol. 9(3): 274-280 doi:10.1016/j.coph.2009. 02.007. PMID:19321386.
39. Upton, P.D., Davies, R.J., Trembath, R.C., and Morrell, N.W. 2009. BMP and activin type-II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells. J. Biol. Chem. 284(23): 15794-15804. doi:10.1074/jbc.M109.002881. PMID:19366699.
40. Wang, H.L., Dong, X., Zhang, X.H., and Xing, J. 2001. 5-HT1B receptor augmented 5-HT vasoconstrictor response of pulmonary artery in monocrotaline-induced pulmonary hypertensive rats. Acta Pharmacol. Sin. 22(3): 269-273. PMID:11742576.
41. Yu, P.B., Deng, D.Y., Beppu, H., Hong, C.C., Lai, C., Hoyng, S.A., et al. 2008. Bone morphogenetic protein (BMP) type II receptor is required for BMP-mediated growth arrest and differentiation in pulmonary artery smooth muscle cells. J. Biol. Chem. 283(7): 3877-3888. doi:10.1074/jbc.M706797200. PMID:18042551.
42. Zaiman, A.L., Podowski, M., Medicherla, S., Gordy, K., Xu, F., Zhen, L., et al. 2008. Role of the TGF-b/Alk5 signaling pathway in monocrotaline-induced pulmonary hypertension. Am. J. Respir. Crit. Care Med. 177(8): 896-905. doi:10.1164/rccm.200707-1083OC. PMID:18202349.
43. Zakrzewicz, A., Hecker, M., Marsh, L.M., Kwapiszewska, G., Nejman, B., Long, L., et al. 2007. Receptor for activated C-kinase 1, a novel interaction partner of type II bone morphogenetic protein receptor, regulates smooth muscle cell proliferation in pulmonary arterial hypertension. Circulation, 115(23): 2957- 2968 doi:10.1161/CIRCULATIONAHA.106.670026. PMID:17515463.
44. Zhai, F.G., Zhang, X.H., and Wang, H.L. 2009. Fluoxetine protects against monocrotaline-induced pulmonary arterial hypertension: potential roles of induction of apoptosis and upregulation of Kv1.5 channels in rats. Clin. Exp. Pharmacol. Physiol. 36(8): 850-856. doi:10.1111/j.1440-1681.2009.05168.x. PMID:19298536.